These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 434817)

  • 1. Proton nuclear magnetic resonance analysis of anomeric structure of glycosphingolipids. Blood group ABH-active substances.
    Falk KE; Karlsson KA; Samuelsson BE
    Arch Biochem Biophys; 1979 Jan; 192(1):177-90. PubMed ID: 434817
    [No Abstract]   [Full Text] [Related]  

  • 2. Proton nuclear magnetic resonance analysis of anomeric structure of glycosphingolipids. Lewis-active and Lewis-like substances.
    Falk KE; Karlsson KA; Samuelsson BE
    Arch Biochem Biophys; 1979 Jan; 192(1):191-202. PubMed ID: 434818
    [No Abstract]   [Full Text] [Related]  

  • 3. Proton nuclear magnetic resonance analysis of anomeric structure of glycosphingolipids. The globo-series (one to five sugars).
    Falk KE; Karlsson KA; Samuelsson BE
    Arch Biochem Biophys; 1979 Jan; 192(1):164-76. PubMed ID: 434816
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunochemistry of the Lewis-blood-group system: proton nuclear magnetic resonance study of plasmatic Lewis-blood-group-active glycosphingolipids and related substances.
    Dabrowski J; Hanfland P; Egge H; Dabrowski U
    Arch Biochem Biophys; 1981 Aug; 210(1):405-11. PubMed ID: 7294835
    [No Abstract]   [Full Text] [Related]  

  • 5. [Macromolecular glycolipids with ABH-blood group activity].
    Thiele OW
    ZFA (Stuttgart); 1980 May; 56(13):921-2. PubMed ID: 7415461
    [No Abstract]   [Full Text] [Related]  

  • 6. Purification and structures of branched blood-group-B-active glycosphingolipids from human erythrocyte membranes.
    Hanfland P; Kordowicz M; Niermann H; Egge H; Dabrowski U; Peter-Katalinic J; Dabrowski J
    Eur J Biochem; 1984 Dec; 145(3):531-42. PubMed ID: 6510415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human blood group glycosphingolipids of porcine erythrocytes.
    Sako F; Gasa S; Makita A; Hayashi A; Nozawa S
    Arch Biochem Biophys; 1990 Apr; 278(1):228-37. PubMed ID: 1690965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further characterization of type 2 and type 3 chain blood group A glycosphingolipids from human erythrocyte membranes.
    Clausen H; Levery SB; Nudelman E; Baldwin M; Hakomori S
    Biochemistry; 1986 Nov; 25(22):7075-85. PubMed ID: 3801409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of glycosphingolipids by high-resolution proton nuclear magnetic resonance spectroscopy.
    Dabrowski J; Hanfland P; Egge H
    Methods Enzymol; 1982; 83():69-86. PubMed ID: 7098951
    [No Abstract]   [Full Text] [Related]  

  • 10. The mono- and difucosyl blood group B glycosphingolipids of rat large intestine differ in type of core saccharide.
    Angström J; Falk P; Hansson GC; Holgersson J; Karlsson H; Karlsson KA; Strömberg N; Thurin J
    Biochim Biophys Acta; 1987 Oct; 926(1):79-86. PubMed ID: 3651504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of glycosphinoglipids by high-resolution 1H nuclear magnetic resonance spectroscopy.
    Dabrowski J; Hanfland P; Egge H
    Biochemistry; 1980 Nov; 19(24):5652-8. PubMed ID: 7459337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood group type glycosphingolipids of human cord blood erythrocytes.
    Larson G; Samuelsson BE
    J Biochem; 1980 Sep; 88(3):647-57. PubMed ID: 7419515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structures of fucose-containing ceramide pentasaccharides from the plasma of blood group O Le(a-b-) nonsecretors.
    Pfannschmidt G; Peter-Katalinić J; Kordowicz M; Egge H; Dabrowski J; Dabrowski U; Hanfland P
    FEBS Lett; 1984 Aug; 174(1):55-60. PubMed ID: 6468659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution proton NMR studies of gangliosides. 1. Use of homonuclear two-dimensional spin-echo J-correlated spectroscopy for determination of residue composition and anomeric configurations.
    Koerner TA; Prestegard JH; Demou PC; Yu RK
    Biochemistry; 1983 May; 22(11):2676-87. PubMed ID: 6307345
    [No Abstract]   [Full Text] [Related]  

  • 15. Isolation and purification of Lewis blood-group active glycosphingolipids from the plasma of human O Leb individuals.
    Hanfland P
    Eur J Biochem; 1978 Jun; 87(1):161-70. PubMed ID: 668686
    [No Abstract]   [Full Text] [Related]  

  • 16. Structural characterization of a blood group A heptaglycosylceramide with globo-series structure. The major glycolipid based blood group A antigen of human kidney.
    Breimer ME; Jovall PA
    FEBS Lett; 1985 Jan; 179(1):165-72. PubMed ID: 3965299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of erythrocytic carrier molecules (glycosphingolipids) with ABO and Le specificity].
    Hauser R; Rand S; Brinkmann B
    Beitr Gerichtl Med; 1989; 47():149-52. PubMed ID: 2818472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic biochemistry of cell surface carbohydrates and aspects of the tissue distribution of histo-blood group ABH and related glycosphingolipids.
    Holgersson J; Breimer ME; Samuelsson BE
    APMIS Suppl; 1992; 27():18-27. PubMed ID: 1520526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 13C-nuclear magnetic resonance of glycosphingolipids.
    Taki T; Kuroyanagi M; Yoshioka H; Handa S
    J Biochem; 1992 May; 111(5):614-9. PubMed ID: 1639757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-group-ABH antigens of human erythrocytes. Quantitative studies on the distribution of H antigenic sites among different classes of membrane components.
    Schenkel-Brunner H
    Eur J Biochem; 1980 Mar; 104(2):529-34. PubMed ID: 6153982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.